Exelixis, Inc. (EXEL)
56.91
+2.27
(+4.15%)
USD |
NASDAQ |
Sep 01, 16:00
56.72
-0.19
(-0.33%)
After-Hours: 20:00
Exelixis Net Income (TTM) : 860.62M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 860.62M |
| March 31, 2026 | 833.42M |
| December 31, 2025 | 782.57M |
| September 30, 2025 | 677.90M |
| June 30, 2025 | 602.30M |
| March 31, 2025 | 643.57M |
| December 31, 2024 | 521.27M |
| September 30, 2024 | 466.92M |
| June 30, 2024 | 349.99M |
| March 31, 2024 | 205.05M |
| December 31, 2023 | 207.76M |
| September 30, 2023 | 92.07M |
| June 30, 2023 | 164.24M |
| March 31, 2023 | 153.74M |
| December 31, 2022 | 182.28M |
| September 30, 2022 | 307.62M |
| June 30, 2022 | 272.62M |
| March 31, 2022 | 298.04M |
| December 31, 2021 | 231.06M |
| September 30, 2021 | 164.28M |
| June 30, 2021 | 94.04M |
| March 31, 2021 | 64.77M |
| December 31, 2020 | 111.78M |
| September 30, 2020 | 152.14M |
| June 30, 2020 | 281.63M |
| Date | Value |
|---|---|
| March 31, 2020 | 293.85M |
| December 31, 2019 | 321.01M |
| September 30, 2019 | 612.36M |
| June 30, 2019 | 641.54M |
| March 31, 2019 | 649.99M |
| December 31, 2018 | 690.07M |
| September 30, 2018 | 368.47M |
| June 30, 2018 | 323.00M |
| March 31, 2018 | 253.10M |
| December 31, 2017 | 153.89M |
| September 30, 2017 | 150.52M |
| June 30, 2017 | 58.08M |
| March 31, 2017 | 5.644M |
| December 31, 2016 | -70.22M |
| September 30, 2016 | -146.91M |
| June 30, 2016 | -183.19M |
| March 31, 2016 | -191.72M |
| December 31, 2015 | -167.66M |
| September 30, 2015 | -184.05M |
| June 30, 2015 | -199.04M |
| March 31, 2015 | -229.09M |
| December 31, 2014 | -268.54M |
| September 30, 2014 | -281.34M |
| June 30, 2014 | -285.90M |
| March 31, 2014 | -274.65M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| BioMarin Pharmaceutical, Inc. | 72.97M |
| Cytokinetics, Inc. | -894.00M |
| Emergent BioSolutions, Inc. | -176.80M |
| Gilead Sciences, Inc. | -3.24B |